March 25, 2022

The state of women in the workplace hangs in the balance

This is some text inside of a div block.

Women face an array of unique stressors — many of which have been compounded by the COVID-19 pandemic. This reality has led to women experiencing higher rates of burnout than their male colleagues. And as a result, women are leaving the workforce at record rates. Fortunately, employers have the incredible power to chip away at, and even dismantle the systems of oppression that contribute to the poor mental health in women. But the question becomes, how?

This webinar features Juliette McClendon, Ph.D., Director of Medical Affairs at Big Health, and Dr. Madeleine Makori, Sr. Medical Science Liaison at Big Health, as they seek to answer that very question.    

In this feature, Dr. McClendon & Dr. Makori discuss the following topics:

  • The unique stressors women face in the US
  • The role intersectionality plays in women’s mental health.
  • How sexism and gender-based discrimination shows up in the workplace
  • Ways that employers can create systemic reform to enhance women’s mental health and lift female voices to keep them in the workforce

Watch the replay

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.

1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.

DOC-3046 Effective 11/2023